Dr. William Harwin, M.D.
What this data tells you about Dr. Harwin
Dr. William Harwin is a hematology in Fort Myers, FL, with 20 years in practice. Based on federal Medicare data, Dr. Harwin performed 85,686 Medicare services across 2,616 unique beneficiaries.
Between the years covered by Open Payments, Dr. Harwin received a total of $68,047 from 59 pharmaceutical and/or device companies across 257 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Harwin is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 18,200 | $43 | $137 |
| Iron infusion (Feraheme) | 17,340 | $0 | $4 |
| Anti-nausea injection (aprepitant) | 11,440 | $1 | $5 |
| Nivolumab injection (Opdivo) | 9,820 | $24 | $72 |
| Epoetin alfa injection (Procrit) for anemia | 7,590 | $6 | $23 |
| Denosumab injection (Prolia/Xgeva) | 7,140 | $18 | $51 |
| Dexamethasone injection (steroid) | 2,926 | $0 | $3 |
| Complete blood count (CBC) with differential | 1,469 | $8 | $29 |
| Blood draw (venipuncture) | 1,288 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,230 | $1 | $28 |
| Office visit, established patient (30-39 min) | 1,034 | $97 | $339 |
| Injection, fulvestrant, 25 mg | 960 | $9 | $132 |
| Injection, leucovorin calcium, per 50 mg | 626 | $3 | $12 |
| Anti-nausea injection (ondansetron/Zofran) | 464 | $0 | $9 |
| Injection of additional new drug or substance into vein | 438 | $12 | $61 |
| Injection, fluorouracil, 500 mg | 428 | $2 | $7 |
| Administration of chemotherapy into vein, 1 hour or less | 426 | $101 | $378 |
| Drug injection, under skin or into muscle | 403 | $11 | $69 |
| Office visit, established patient (20-29 min) | 214 | $71 | $239 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 183 | $48 | $189 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 179 | $22 | $84 |
| Infusion into a vein for hydration, each additional hour | 175 | $10 | $42 |
| Injection, diphenhydramine hcl, up to 50 mg | 152 | $1 | $3 |
| Infusion, normal saline solution , 1000 cc | 142 | $2 | $7 |
| Injection, zoledronic acid, 1 mg | 136 | $6 | $69 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 122 | $16 | $56 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 121 | $26 | $89 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 107 | $135 | $562 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 104 | $17 | $59 |
| Infusion into a vein for hydration, 31-60 minutes | 95 | $25 | $156 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 95 | $57 | $206 |
| Administration of additional new drug or substance into vein using push technique | 81 | $44 | $170 |
| Administration of chemotherapy into vein, each additional hour | 80 | $22 | $79 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 75 | $1 | $6 |
| Administration of additional new drug or substance into vein, 1 hour or less | 71 | $50 | $178 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 49 | $131 | $637 |
| Automated urinalysis | 47 | $2 | $8 |
| Injection of drug or substance into vein | 47 | $29 | $156 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 42 | $3 | $11 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 40 | $16 | $56 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 33 | $1 | $7 |
| Office visit, established patient, complex (40-54 min) | 26 | $145 | $474 |
| New patient office visit, complex (60-74 min) | 20 | $171 | $585 |
| Office visit, established patient (10-19 min) | 16 | $46 | $147 |
| New patient office visit (45-59 min) | 12 | $136 | $453 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (48%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for hematology in FL.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | — Not enrolled | N/A |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Harwin is a mixed practice specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 8%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Harwin experienced with pembrolizumab injection (keytruda)?
Does Dr. Harwin receive payments from pharmaceutical companies?
How do Dr. Harwin's costs compare to other hematologys in Fort Myers?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology